FDA Inspection 1041550 - Philip NMI Raskin - February 20, 2018

Record Details

This FDA Inspection record concerns Philip NMI Raskin, with an inspection on February 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Philip NMI Raskin
Inspection Date: February 20, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 779f9eca-7e9d-4191-b479-a8f527415e82

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.